Added to YB: 2026-08-26
Pitch date: 2026-08-20
BSX [neutral]
Boston Scientific Corporation
+1.3%
current return
Author Info
No bio for this author
Company Info
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
Market Cap
$73.0B
Pitch Price
$49.22
Price Target
N/A
Dividend
N/A
EV/EBITDA
14.94
P/E
20.41
EV/Sales
4.06
Sector
Health Care Equipment and Supplies
Category
growth
The market punishes, my algorithm hunts: 17 potential opportunities in the S&P 500 - Boston Scientific Corporation
BSX (quick overview): Algo flags a wide fundamentals-vs-price gap: net profit +119% and revenue +44% while the stock barely moved. FCF ample, ROIC rising, and net debt at 2.1x is deleveraging—author's variant view is a growth compounder (aging-population tailwind, recurring hospital demand) the market has refused to re-rate.
Read full article (1 min)